Recent reports suggest that SpaceX could go public in 2026, and Elon Musk has hinted that this is likely. Musk's space company could go public at a colossal $1.5 trillion valuation. Rumors of the historic offering have boosted enthusiasm for space stocks in the last week. Talk of a colossal 2026 IPO from SpaceX is already having an impact on the market. Investors have been asking for years if Elon Musk will ever allow SpaceX to start trading on public markets, and reports indicate next year could ...

Core Viewpoint - Redwire stock has experienced significant gains over the past year, but current market conditions suggest it may be time to sell despite winning a NASA contract for a space biotechnology experiment [1][6]. Company Summary - Redwire has secured a NASA contract to facilitate a Space Microalgae biotechnology experiment, which will be conducted aboard the upcoming Axiom Mission 4 to the International Space Station [1][4]. - The experiment aims to analyze the growth, metabolism, and genetic activity of three strains of edible microalgae, potentially serving as a sustainable food source for long-duration space missions [4]. Financial Performance - Redwire's stock has more than tripled in price over the past year, currently valued at $1.5 billion, but the company has no profits and less than $280 million in revenue [6]. - The stock carries a price-to-sales ratio of over 5.3, which is significantly higher than the estimated range of 2 to 4 times trailing sales for profitless space stocks [6][7]. - A year ago, Redwire stock was valued at only 1.4 times sales, indicating a substantial increase in valuation [6].